×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
FDA Legislation 2025: How is Congress Preparing to Advance Innovation, Medical Product Safety, and FDA Funding?
Session Chair(s)
Jeffrey Francer, JD, MPA
Vice President, Head of Global Regulatory Policy & Strategy
Eli Lilly and Company, United States
The forum will explore key legislative proposals affecting FDA regulation of drugs and devices, while FDA and industry prepare to negotiate the next round of user fees and performance goals.
Learning Objective : Describe key legislative initiatives that could alter FDA's regulation of drugs and medical devices; Understand the interplay between current FDA legislative proposals and the upcoming FDA user fee negotiations and legislation; Consider the impact of legislative proposals on FDA and regulated industries.
Have an account?